Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SARA JEAN SUTTON-MEYER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1457911075
CMS profile
10826220
Location
BURGAW, NC

General Payments · PY2021–2024

$1,547.96

  • Reported across 92 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$316.97

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $316.97 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $185.04 7
Novo Nordisk AS $56.17 3
Exact Sciences Corporation $31.50 2
GlaxoSmithKline, LLC. $22.57 1
Astellas Pharma US Inc $21.69 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $577.80 39
PY2022 $295.82 18
PY2023 $357.37 21
PY2024 $316.97 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $21.69 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139511095 CMS
AstraZeneca Pharmaceuticals LP $15.54 01/02/2024 Food and Beverage Undisputed 01/23/2026 1105847065 CMS
AstraZeneca Pharmaceuticals LP $13.79 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105219006 CMS
AstraZeneca Pharmaceuticals LP $19.93 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105396380 CMS
AstraZeneca Pharmaceuticals LP $16.76 02/12/2024 Food and Beverage Undisputed 01/23/2026 1105569057 CMS
AstraZeneca Pharmaceuticals LP $73.32 02/20/2024 Food and Beverage Undisputed 01/23/2026 1105753007 CMS
AstraZeneca Pharmaceuticals LP $21.15 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105761042 CMS
AstraZeneca Pharmaceuticals LP $24.55 07/09/2024 Food and Beverage Undisputed 01/23/2026 1105838617 CMS
Exact Sciences Corporation $15.70 07/30/2024 Food and Beverage Undisputed 01/23/2026 1114477336 CMS
Exact Sciences Corporation $15.80 10/21/2024 Food and Beverage Undisputed 01/23/2026 1114477346 CMS
GlaxoSmithKline, LLC. $22.57 05/09/2024 Food and Beverage Undisputed 01/23/2026 1116669076 CMS
Novo Nordisk Inc $19.75 01/16/2024 Food and Beverage Undisputed 01/23/2026 1100548886 CMS
Novo Nordisk Inc $16.97 04/03/2024 Food and Beverage Undisputed 01/23/2026 1100454202 CMS
Novo Nordisk Inc $19.45 05/09/2024 Food and Beverage Undisputed 01/23/2026 1100238522 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.